Taiwanese Journal of Obstetrics and Gynecology
Volume 48, Issue 3 , Pages 239-244 , September 2009

Mechanisms of Chemotherapeutic Drug Resistance in Cancer Therapy—A Quick Review

  • Fu-Shing Liu

      Affiliations

    • Corresponding Author InformationCorrespondence to: Dr Fu-Shing Liu, Department of Obstetrics and Gynecology, Show Chwan Memorial Hospital, 542, Section 1, Chung-Shang Road, Changhua 500, Taiwan

,Accepted 10 March 2009.

References 

  1. Huang Y . Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy . Cancer Metastasis Rev . 2007;26:183–201
  2. Stavrovskaya AA , Stromskaya TP . Transport proteins of the ABC family and multidrug resistance of tumor cells . Biochemistry . 2008;73:592–604
  3. Sarkadi B , Homolya L , Szakacs G , Varadi A . Human multidrug resistance ABCB and ABCG transporters: participation in chemoimmunity defense system . Physiol Rev . 2006;86:1179–1236
  4. Hrycyna CA, Ramachandra M, Ambudkar SV, Ko YH, Pedersen PL, Pastan I, et al. Mechanism of action of human P-glycoprotein ATPase activity: photochemical cleavage during a catalytic transition state using orthovanadate reveals cross-talk between the two ATP sites . J Biol Chem . 1998;273:16631–16634
  5. Ambudkar SV , Kimchi-Sarfaty C , Sauna ZE , Gottesman MM . P-glycoprotein: from genomics to mechanism . Oncogene . 2003;22:7468–7485
  6. Bourguignon LYW , Peyrollier K , Xia W , Gilad E . Hyaluronan-CD44 interaction activates stem cell marker, Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells . J Biol Chem . 2008;283:17635–17651
  7. Chang XB . A molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1 . Cancer Metastasis Rev . 2007;26:15–37
  8. Chen YN , Mickley LA , Schwartz AM , Acton EM , Hwang J , Fojo AT . Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein . J Biol Chem . 1990;265:10073–10080
  9. Robey RW , Polgar O , Deeken J , To KW , Bates SE . ABCG2: determining its relevance in clinical drug resistance . Cancer Metastasis Rev . 2007;26:39–57
  10. Kuo MT , Chen HHW , Song IS , Savaraj N , Ishikawa T . The roles of copper transporters in cisplatin resistance . Cancer Metastasis Rev . 2007;26:71–83
  11. Wang D , Lippard SJ . Cellular processing of platinum anticancer drugs . Nat Rev Drug Discov . 2005;4:307–320
  12. Siddik ZH . Cisplatin: mode of cytotoxic action and molecular basis of resistance . Oncogene . 2003;22:7265–7279
  13. Samimi G , Safaei R , Katano K , et al.   Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells . Clin Cancer Res . 2004;10:4661–4669
  14. Samimi G , Varki NM , Wilczynski S , Safaei R , Alberts DS , Howell SB . Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients . Clin Cancer Res . 2003;9:5853–5859
  15. Donnenberg VS , Donnenberg AD . Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis . J Clin Pharmacol . 2005;45:872–877
  16. Lou H , Dean M . Targeted therapy for cancer stem cells: the patched pathway and ABC transporters . Oncogene . 2007;26:1357–1360

PII: S1028-4559(09)60296-5

doi: 10.1016/S1028-4559(09)60296-5

Taiwanese Journal of Obstetrics and Gynecology
Volume 48, Issue 3 , Pages 239-244 , September 2009

Article Tools